anxiety
Conditions
Interventions
anxiety group:Intravenous injection of ciprofol 0.2mg/kg as the statring dose
non-anxiety group:Intravenous injection of ciprofol 0.2mg/kg as the statring dose
Sponsors
Affiliated Hospital of Shaoxing University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Voluntarily undergoing painless induced abortion; 2. Aged between 18 and 45 years; 3. Classified as American Society of Anesthesiologists (ASA) I–II; 4. Body mass index (BMI) between 18 and 28 kg/m².
Exclusion criteria
Exclusion criteria: 1. Allergy to opioids and/or propofol; 2. Myasthenia gravis; 3. Schizophrenia or severe depressive disorder; 4. Acute upper respiratory tract infection; 5. History of long-term use of sedative or analgesic medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In combination with alfentanil, ciprofol inhibits the ED90 of the patient's body movement response when the cervix is dilated;Anxiety scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean arterial pressure;Heart rate;Oxygen saturation;Adverse reaction incidence rate; | — |
Countries
China
Contacts
Public ContactBaozhu Cha
Affiliated Hospital of Shaoxing University
Outcome results
None listed